Medicine

~ Company now owns full global rights to late-stage program with clinical proof-of-concept ~

Roche today announced that the US FDA has granted breakthrough therapy designation for Venclexta® (venetoclax) in combination with low dose cytarabine (LDAC) for elderly patients with previously untreated AML who are ineligible for intensive chemotherapy.

Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development

Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2017

Wolbachia inhibits Zika virus replication.

Maternal obesity has been linked to a higher risk of behavioral problems in boys, according to a new study co-authored by public health professors Julianna Deardorff and Barbara Abrams.

Valeant Pharmaceuticals International, Inc. today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P.

Roche announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)

Amgen today announced the submission of a sNDA to the U.S. FDA and a variation to the marketing application to the EMA to include OS data from the Phase 3 head-to-head ENDEAVOR trial in the product information for KYPROLIS® (carfilzomib).

- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted that the results of ALFA-0701 demonstrated a favorable risk

Sanofi announced today it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut in the United States.

Takeda Pharmaceutical Company and Axcelead Drug Discovery Partners, Inc. today announced the start of operations for AXCELEAD occurred on July 1, 2017

Market News alert Avacta Group PLC

Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections